Venkat Jasti, CEO of Suven Life Sciences in an interview with CNBC-TV18 spoke about the performance of the company and the road ahead.
Below is the verbatim transcript of his interview with Sonia Shenoy and Ekta Batra of CNBC-TV18. Also watch the accompanying video. Q: You are sitting on a total income of about Rs 150 crore as a base for FY11. Going into FY12 what kind of a growth are you expecting to see and if you could break it up for us in terms of manufacturing and services as well segment wise performance where you are expecting the driver to come from? A: I expect the total growth to be to the tune of 20%. Out of this most of the growth will be in the CRAMSDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
